Aballi John's Form 4/A amendment
AmendedExagen Inc. (XGN) · filed Feb 25, 2025
- Accession no.
- 0001274737-25-000009
- Filed
- Feb 25, 2025
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 18, 2024
This filing lists no transactions. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $68.3K.
This amendment restates part of 0001274737-24-000094 (filed Nov 18, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aballi JohnCIK 0001843113 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001274737-24-000094 (filed Nov 18, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | Common Stock | PPurchaseAcquired | +24,305 | $2.81F1 | +$68,297.05 | 689,799 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.94, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On November 18, 2024, the reporting person filed a Form 4 which inadvertently reported that, following his purchase of 24,305 shares of common stock, he directly owned 689,799 shares of common stock. In fact, as reported in this amendment, the reporting person directly owned 625,093 shares of common stock and indirectly owned 40,401 shares of common stock.